HCW Biologics Inc.
HCWB· Nasdaq
HCWBHCW Biologics Inc.
Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0000950170-21-004237
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Net Income | -$4.09M | -$2.71M |
| EPS Diluted | -$0.14 | -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
HCW Biologics Inc. · CIK 1828673 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end
